Comprehensive Cytokine Profiling of Patients with COVID-19 Receiving Tocilizumab Therapy
토실리주맙 치료를 받는 COVID-19 환자의 종합적인 사이토카인 프로파일링
Article
Published on
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 진단,
Journal: International Journal of Molecular Sciences [Category] COVID19(2023년), SARS, 진단,
[키워드] addition
Administered
administration
Admission
analyzed
anti-cytokine
anti-cytokine therapy
Blood
changes
characterized
circulating cytokine
Clinical endpoints
Cluster
Comprehensive
Concentration
Coronavirus disease 2019
correlated
COVID-19
criteria
CSS
cytokine
cytokine profile
Cytokine storm
Cytokine storm syndrome
Cytokines
defined
demonstrated
disease severity
Follow-up
follow-up period
G-CSF
group
hospitalized patient
IL-10
IL-1ra
IL-6
immune activation
in both group
increased mortality
indication
Inflammation
interleukin
Laboratory
laboratory parameter
multiple cytokines
multiplex
parameter
pathophysiological mechanism
Patient
performed
plasma
Profiling
Prognosis
separated
Severe case
the patient
to define
Tocilizumab
tocilizumab therapy
treatment with tocilizumab
viral spread
with COVID-19
[DOI] 10.3390/ijms23147937 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/ijms23147937 PMC 바로가기 [Article Type] Article